COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,712 Articles (22,913 medRxiv, 8,799 bioRxiv)

Most recent first Previous |  Page 2877: Articles 28761-28770  | Next

Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study
Wu, G., Yang, P., Woodruff, H. C., Rao, X., Guiot, J., Frix, A.-N., Moutschen, M., Louis, R., Li, J., Li, J., Yan, C., Du, D., Zhao, S., Ding, Y., Liu, B., Sun, W., Albarello, F., D'Abramo, A., Schinina, V., Nicastri, E., Occhipinti, M., Barisione, G., Barisione, E., Halilaj, I., Xie, Y., Wang, X., Lovinfosse, P., Wu, J., Lambin, P.
10.1101/2020.05.01.20053413 — Posted: 2020-05-07
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.
The OpenSAFELY Collaborative, , Williamson, E., Walker, A. J., Bhaskaran, K. J., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., Cockburn, J., Mcdonald, H. I., MacKenna, B., Tomlinson, L., Douglas, I. J., Rentsch, C. T., Mathur, R., Wong, A., Grieve, R., Harrison, D., Forbes, H., Schultze, A., Croker, R. T., Parry, J., Hester, F., Harper, S., Perera, R., Evans, S., Smeeth, L., Goldacre, B.
10.1101/2020.05.06.20092999 — Posted: 2020-05-07 Discussion: Onsite | Offsite
A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Wu, Y., Wang, F., Shen, C., Peng, W., Li, D., Zhao, C., Li, Z., Li, S., Bi, Y., Yang, Y., Gong, Y., Xiao, H., Fan, Z., Tan, S., Wu, G., Tan, W., Lu, X., Fan, C., Wang, Q., Liu, Y., Qi, J., Gao, G. F., Gao, F., Liu, L.
10.1101/2020.05.01.20077743 — Posted: 2020-05-07 Discussion: Onsite | Offsite
Effects of Coronavirus Disease 2019 (COVID-19) on Maternal, Perinatal and Neonatal Outcomes: a Systematic Review of 266 Pregnancies
Juan, J., Gil, M. M., Rong, Z., Zhang, Y., Yang, H., Poon, L. C. Y.
10.1101/2020.05.02.20088484 — Posted: 2020-05-06
Validation of a commercially available SARS-CoV-2 serological Immunoassay
Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., Kaiser, L.
10.1101/2020.05.02.20080879 — Posted: 2020-05-06
A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates
Meyerowitz-Katz, G., Merone, L.
10.1101/2020.05.03.20089854 — Posted: 2020-05-06 Discussion: Onsite
The importance of the timing of quarantine measures before symptom onset to prevent COVID-19 outbreaks - illustrated by Hong Kong's intervention model
Yuan, H.-Y., Han, G., Yuan, H., Pfeiffer, S., Mao, A., Wu, L., Pfeiffer, D.
10.1101/2020.05.03.20089482 — Posted: 2020-05-06 Discussion: Offsite
A note on COVID-19 seroprevalence studies: a meta-analysis using hierarchical modelling
Levesque, J., Maybury, D. W.
10.1101/2020.05.03.20089201 — Posted: 2020-05-06
Clinical characteristics and fecal-oral transmission potential of patients with COVID-19
Wang, S., Tu, J., Sheng, Y.
10.1101/2020.05.02.20089094 — Posted: 2020-05-06
The impact of long-term non-pharmaceutical interventions on COVID-19 epidemic dynamics and control
Childs, M. L., Kain, M. P., Kirk, D., Harris, M., Couper, L., Nova, N., Delwel, I., Ritchie, J., Mordecai, E. A.
10.1101/2020.05.03.20089078 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).